Business
FDA Orphan Drug Designation - Idiopathic Pulmonary Fibrosis
FDA Orphan Drug Designation - Idiopathic Pulmonary Fibrosis
About this update from Amplia Therapeutics Ltd.
[{"type":"text","content":"Amplia Therapeutics Ltd has released a press release. View Attachment","length":248,"tagName":"div"}]